Li, Bin |
| Recruiting | 4 | 162 | RoW | Qishenyiqi dripping pills 1 bag, three times a day, Placebo 1 bag, three times a day | Qilu Hospital of Shandong University | Coronary Microvascular Disease | 12/25 | 06/26 | | |
| Not yet recruiting | 4 | 162 | RoW | Danshen Dripping Pill, Placebo | Qilu Hospital of Shandong University | Diabetic Microvascular Angina | 12/26 | 06/27 | | |
TQB2450-AL2846-III-01, NCT05922345: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. |
|
|
| Recruiting | 3 | 518 | RoW | TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules, TQB2450 placebo, docetaxel injection, AL2846 matching placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non-small Cell Lung Cancer | 08/25 | 12/25 | | |
NCT03153293: A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy |
|
|
| Active, not recruiting | 2/3 | 159 | RoW | rAAV2-ND4 | Huazhong University of Science and Technology, Shiyan Taihe Hospital | Leber Hereditary Optic Neuropathy | 01/20 | 01/25 | | |
GOLD, NCT04912843: Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy |
|
|
| Recruiting | 2/3 | 102 | RoW | NR082 injection, Sham Injection | Wuhan Neurophth Biotechnology Limited Company | Leber's Hereditary Optic Neuropathy (LHON) | 02/24 | 02/28 | | |
NCT06413654: A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) |
|
|
| Recruiting | 2/3 | 132 | RoW | B001, Placebo | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Neuromyelitis Optica Spectrum Disorders | 10/27 | 02/29 | | |
HYPERION, NCT05281003: Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004) |
|
|
| Recruiting | 2 | 128 | RoW | Pembrolizumab, Keytruda, MK-3475, Paclitaxel, Cisplatin | Fudan University, Merck Sharp & Dohme LLC | Esophageal Squamous Cell Carcinoma | 09/23 | 09/26 | | |
NCT06152978: A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma |
|
|
| Not yet recruiting | 2 | 182 | RoW | Sintilimab, Chemotherapy | Fudan University, Innovent Biologics (Suzhou) Co. Ltd. | Esophageal Squamous Cell Carcinoma | 12/25 | 12/27 | | |
NCT05944224: A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. |
|
|
| Recruiting | 1/2 | 63 | RoW | SPH4336, Cadonilimab | Shanghai Pharmaceuticals Holding Co., Ltd | Advanced Solid Tumors | 05/25 | 12/25 | | |
NCT04006769: Entacapone Combination With Imatinib for Treatment of GIST |
|
|
| Completed | 1 | 5 | RoW | Entacapone, Comtan, Comtess, Imatinib Mesylate, Gleevec | Xiangya Hospital of Central South University | Gastrointestinal Stromal Tumor, Malignant | 08/22 | 08/22 | | |
NCT06114173: Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma |
|
|
| Active, not recruiting | 1 | 15 | RoW | Cardunilizumab, PD-1/CTLA-4 Bispecific Antibody | Xiangya Hospital of Central South University | Sarcoma, Soft Tissue | 06/23 | 11/24 | | |
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) |
|
|
| Active, not recruiting | N/A | 1000 | RoW | BuMA Supreme | Sino Medical Sciences Technology Inc. | Coronary Artery Disease | 05/19 | 12/25 | | |
| Recruiting | N/A | 1124 | RoW | Robot-assisted lobectomy, Video-assisted lobectomy | Sun Yat-sen University, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital of Qingdao University, The General Hospital of Eastern Theater Command, Gansu Provincial Hospital, Tang-Du Hospital, Wuhan TongJi Hospital, First Affiliated Hospital of Chongqing Medical University, West China Hospital, Wuhan Union Hospital, China, Shenzhen People's Hospital, The First Affiliated Hospital of Zhengzhou University, Shandong Provincial Hospital, Jiangsu Cancer Institute & Hospital, Guangdong Provincial People's Hospital, Liaoning Tumor Hospital & Institute, Qilu Hospital of Shandong University, Jiangxi Provincial People's Hopital, Sichuan Cancer Hospital and Research Institute, The Second Hospital of Lanzhou University, Shenzhen Third People's Hospital | Non Small Cell Lung Cancer | 12/24 | 12/29 | | |
NCT05034549: Noninvasive Ventilation for Chronic Heart Failure |
|
|
| Recruiting | N/A | 150 | RoW | Noninvasive ventilation | Qilu Hospital of Shandong University | Chronic Stable Heart Failure | 02/23 | 08/23 | | |
NCT05167149: Carbon Nanoparticles and Indocyanine Green for Sentinel Lymph Node Biopsy in Early Stage Cervical Cancer |
|
|
| Not yet recruiting | N/A | 144 | RoW | Carbon nanoparticles, Indocyanine green | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Cervical Cancer Stage IB1 | 06/23 | 06/23 | | |
NCT06399926: Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir |
|
|
| Recruiting | N/A | 64 | RoW | Pemetrexed injection, Alimta, Pemetrexed | Xiangya Hospital of Central South University, First People's Hospital of Chenzhou, Xiangtan Central Hospital | Leptomeningeal Metastasis, Lung Cancer | 06/25 | 06/27 | | |
NCT05667350: AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC) |
|
|
| Recruiting | N/A | 492 | RoW | Blood drawing | Eastern Hepatobiliary Surgery Hospital, Guangzhou Burning Rock Bioengineering Co., Ltd | Biliary Tract Cancer | 12/23 | 06/24 | | |
NCT05782881: High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program |
|
|
| Recruiting | N/A | 16000 | RoW | phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2 | Wuhan Union Hospital, China, Peking University First Hospital | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease | 12/23 | 12/24 | | |
NCT05443841: Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005) |
|
|
| Recruiting | N/A | 385 | RoW | pleural lavage | Fudan University | Esophageal Cancer | 07/24 | 07/27 | | |
NCT04967560: The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD |
|
|
| Recruiting | N/A | 64 | RoW | deep brain stimulation | Shanghai Mental Health Center, West China Hospital, Huashan Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Brain Hospital, First Affiliated Hospital of Kunming Medical University, Changhai Hospital, SceneRay Corporation, Limited | Obsessive-Compulsive Disorder | 07/24 | 10/24 | | |
NCT05042635: Sequential Treatment of Psoriasis With Traditional Chinese and Western Medicine |
|
|
| Not yet recruiting | N/A | 90 | NA | Ixekizumab+Jueyin Granules, Ixekizumab+Jueyin placebo Granules | Shanghai Yueyang Integrated Medicine Hospital, Shanghai Skin Disease and Venereal Disease Hospital | Plaque Psoriasis | 09/24 | 09/24 | | |
| Recruiting | N/A | 20 | RoW | | Fujian Provincial Hospital | Resectable Hepatocellular Carcinoma | 02/26 | 12/26 | | |
NCT06602011: Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002) |
|
|
| Recruiting | N/A | 20 | RoW | TACE, Lenvatinib, combined with Tislelizumab group | Fujian Provincial Hospital | Hepatocellular Carcinoma | 07/27 | 10/28 | | |
| Recruiting | N/A | 400 | RoW | Thread embedding acupuncture, Sham thread embedding acupuncture | Beijing Hospital of Traditional Chinese Medicine | Obesity and Overweight | 10/26 | 10/26 | | |
HFrEF, NCT06717204: Vericiguat for Heart Failure With Reduced Ejection Fraction After Myocardial Infarction |
|
|
| Not yet recruiting | N/A | 210 | RoW | Vericiguat Oral Tablet [Verquvo], Conventional treatment, Prescription Drugs, Conventional treatment without vericiguat | Qilu Hospital of Shandong University, Jinan Central Hospital, Qianfoshan Hospital | HFrEF - Heart Failure With Reduced Ejection Fraction, Myocardial Infarction (MI) | 12/26 | 12/27 | | |
NCT06738667: Acupuncture for Painful Temporomandibular Disorder |
|
|
| Not yet recruiting | N/A | 48 | RoW | Acupuncture, Sham treatment | Beijing Hospital of Traditional Chinese Medicine | Temporomandibular Disorders (TMD) | 12/26 | 12/26 | | |
NCT04212494: Thrombus Aspiration in STEMI Patients With High Thrombus Burden |
|
|
| Recruiting | N/A | 3838 | RoW | Thrombus aspiration, PCI Alone | Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital | ST-segment Elevation Myocardial Infarction (STEMI) | 08/25 | 02/26 | | |
Cai, Jianchun |
NCT05468944: Robotic Transanal Specimen Extraction Surgery Versus Robotic Transabdominal Incision Specimen Extraction Surgery for Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial |
|
|
| Not yet recruiting | N/A | 556 | RoW | Transanal specimen extraction robotic surgery, Transabdominal specimen extraction robotic surgery | Taiyuan Li | Rectal Neoplasms, Robotic Surgery, Natural Orifice Specimen Extraction Surgery | 12/25 | 12/25 | | |
Ye, Chunsheng |
NCT06431542: Efficacy of Self Vs. Physician Application of Triamcinolone-Econazole in Otomycosis |
|
|
| Completed | 4 | 200 | RoW | physician-applied Triamcinolone Acetonide Econazole Cream, patient-applied Triamcinolone Acetonide Econazole Cream | Zhongshan Hospital Xiamen University | Otomycosis | 10/24 | 10/24 | | |
NCT06530069: Exploring the Risk Factors of Otomycosis: A Case-Control Study |
|
|
| Recruiting | N/A | 200 | RoW | exposures | Zhongshan Hospital Xiamen University | Otomycosis | 08/24 | 08/24 | | |
Zhou, Jian-Yin |
| Recruiting | N/A | 20 | RoW | | Fujian Provincial Hospital | Resectable Hepatocellular Carcinoma | 02/26 | 12/26 | | |
NCT06602011: Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002) |
|
|
| Recruiting | N/A | 20 | RoW | TACE, Lenvatinib, combined with Tislelizumab group | Fujian Provincial Hospital | Hepatocellular Carcinoma | 07/27 | 10/28 | | |